LPDAX | VTTSX | LPDAX / VTTSX | |
Total Expense Ratio | 0.84 | 0.08 | 1,050% |
Annual Report Gross Expense Ratio | 1.10 | 0.08 | 1,375% |
Fund Existence | 8 years | 13 years | - |
Gain YTD | 9.356 | 9.951 | 94% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 127M | 34.8B | 0% |
Annual Yield % from dividends | 2.42 | 1.94 | 124% |
Returns for 1 year | 9.26 | 11.71 | 79% |
Returns for 3 years | 50.22 | 44.91 | 112% |
Returns for 5 years | 65.87 | 55.23 | 119% |
Returns for 10 years | N/A | 104.86 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
LOCT | 23.84 | -0.01 | -0.04% |
Innovator Premium Income 15 Buf ETF -Oct | |||
JANU | 26.08 | -0.16 | -0.61% |
AllianzIM U.S. Equity Buffer15 Uncapped Jan ETF | |||
IFGL | 22.54 | -0.22 | -0.97% |
iShares International Dev Real Est ETF | |||
BBH | 155.68 | -2.02 | -1.28% |
VanEck Biotech ETF | |||
QTUM | 92.34 | -1.21 | -1.29% |
Defiance Quantum ETF |